Company profile for Supriya Lifescience

PharmaCompass

Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Related CompaniesRelated Companies

About

Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
India
Address
Address
207/208 Udyog Bhavan, Sonawala Road, Goregoan [E], Mumbai – 400 063
Telephone
Telephone
+91 2226860012
Contact Info
Others

Events

Webinars & Exhibitions

Digital content read-more

Explore the latest content creation from this company

CORPORATE CONTENT #SupplierSpotlight

    https://www.pharmacompass.com/pdf/party/content/supriya-lifescience-party-content-45074.pdf

    https://www.pharmacompass.com/pdf/party/content/supriya-lifescience-party-content-32145.pdf

    https://www.pharmacompass.com/pdf/party/content/supriya-lifescience-party-content-57092.pdf

    https://www.pharmacompass.com/pdf/party/content/supriya-lifescience-party-content-84447.pdf

    https://www.pharmacompass.com/pdf/party/content/supriya-lifescience-party-content-63376.pdf

NEWS #PharmaBuzz

read-more
read-more

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/supriya-lifescience-opens-new-api-block-at-lote-parshuram-site-in-maharashtra/articleshow/116408363.cms?from=mdr

ECONOMICTIMES
18 Dec 2024

https://www.biospectrumindia.com/news/73/25432/supriya-lifescience-expands-global-footprint-with-esketamine-hydrochloride-approval-atorvastatin-patent-filing.html

PRESS RELEASE
11 Dec 2024

https://www.indianpharmapost.com/news/supriya-lifescience-reports-19-revenue-increase-in-q2-fy25-16378

INDPHARMAPOST
01 Nov 2024

https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-a-promising-smallcap-pharma-stock-with-strong-financials-and-positive-market-performance-294556

MARKETMOJO
29 Oct 2024

https://www.apnnews.com/from-dreams-to-reality-the-remarkable-entrepreneurial-journey-of-dr-satish-wagh-in-the-pharmaceutical-industry/

APNNEWS
25 Oct 2024

https://www.ceoinsightsindia.com/industry-insider/ai-and-precision-medicine-transforming-pharma-industry-nwid-18922.html#google_vignette

CEOINSIGHTINDIA
27 Sep 2024

KEY PRODUCTS

read-more
read-more

TOP RANKED SUPPLIER FOR:

Sponsored Ads.
full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view